Health and Fitness Health and Fitness

Tue, December 13, 2011

[ Tue, Dec 13th 2011 ] - Market Wire

Stem Cell Therapeutics Announces Additions to Advisory Board

[ Tue, Dec 13th 2011 ] - Market Wire

Eindgegevens van Fase II multi-center onderzoek n .. REVLIMID bij patinten met hoogrisico MDS gepresen

[ Tue, Dec 13th 2011 ] - Market Wire

BioLineRx to Develop and Commercialize Novel Peptide Drug Candidates Discovered by Compugen

[ Tue, Dec 13th 2011 ] - Market Wire

UK's National Health System Rejects Drug Therapy for Diabetic Macular Edema

[ Tue, Dec 13th 2011 ] - Market Wire

Estudio de Fase III sobre terapia continuada con .. stadsticamente significativas en la supervivencia

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. reicht Klage ein ge .. Inc. und dessen Chief Scientific Officer und Sen

[ Tue, Dec 13th 2011 ] - Market Wire

Prsentation laASH des rsultats dfinitifs daune tu .. I valuant la combinaison de VIDAZA et de REVLIMID

[ Tue, Dec 13th 2011 ] - Market Wire

Une tude de phase III avec traitement continu de .. ion statistiquement considrable de la survie sans

[ Tue, Dec 13th 2011 ] - Market Wire

Phase-III-Studie mit kontinuierlicher REVLIMID-Th .. ifikante Verbesserung der progressionsfreien berl

[ Tue, Dec 13th 2011 ] - Market Wire

Threshold Pharmaceuticals Announces Update to TH- .. resented at the Oppenheimer Healthcare Conference

[ Tue, Dec 13th 2011 ] - Market Wire

NTRR Targets $390 Billion Weight Loss and Diet Management Market

[ Tue, Dec 13th 2011 ] - Market Wire

FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVEa"

[ Tue, Dec 13th 2011 ] - Market Wire

Radient Pharmaceuticals Launches New Onko-Sure Website, Facebook and Twitter Outreach

[ Tue, Dec 13th 2011 ] - Market Wire

Une tude de dosage value REVLIMID chez des patien .. aits, atteints de leucmie lymphocytaire chronique

[ Tue, Dec 13th 2011 ] - Market Wire

Les rsultats d'une analyse comparative rvlent que .. tistiquement significative le risque de dcs, sans

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. dpose plainte contr .. Inc. et son conseiller scientifique en chef et VP

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. Files Suit Against .. c. and its Chief Scientific Officer and Senior VP

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. fa causa ad Ironwoo .. suo Direttore Scientifico e Vicepresidente Senior

[ Tue, Dec 13th 2011 ] - Market Wire

Synergy Pharmaceuticals, Inc. spant geding aan te .. , Inc. en haar Chief Scientific Officer en Senior

Mon, December 12, 2011

[ Mon, Dec 12th 2011 ] - Market Wire

Abiomed 2011 Investor Day Webcast Replay Available

[ Mon, Dec 12th 2011 ] - Market Wire

First FDA-Approved Treatment for Myelofibrosis, J .. ssed in Multiple Presentations at 2011 ASH Annual

[ Mon, Dec 12th 2011 ] - Market Wire

Paladin Labs Announces the Canadian Launch of DigiFab(TM) Digoxin Immune Fab (Ovine)

[ Mon, Dec 12th 2011 ] - Market Wire

Lilly Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at ASH Meeting

[ Mon, Dec 12th 2011 ] - Market Wire

Community Health Systems Announces Definitive Agreement to Acquire Blue Island, Illinois Hospital

[ Mon, Dec 12th 2011 ] - Market Wire

AMAG Pharmaceuticals Announces Preliminary Data R .. acy of a Single Infusion of 1020 mg Ferumoxytol (

[ Mon, Dec 12th 2011 ] - Market Wire

Nektar Therapeutics Initiates Phase 3 BEACON Tria .. f NKTR-102 in Women with Metastatic Breast Cancer

[ Mon, Dec 12th 2011 ] - Market Wire

ProMetic Announces Achievement of Significant Targeted Milestone With a Multinational Company

[ Mon, Dec 12th 2011 ] - Market Wire

PDL BioPharma Announces Departure of Chief Financial Officer

[ Mon, Dec 12th 2011 ] - Market Wire

Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer

[ Mon, Dec 12th 2011 ] - Market Wire

Mylan Names John Thievon President of Dey Pharma

[ Mon, Dec 12th 2011 ] - Market Wire

Soligenix Announces Publication of Results of its .. al Trial of orBec in the Prevention of Acute GVHD

[ Mon, Dec 12th 2011 ] - Market Wire

MELA Sciences Announces Additions to Board of Directors

[ Mon, Dec 12th 2011 ] - Market Wire

Emergent BioSolutions to Participate in January 2012 Investor Conferences

[ Mon, Dec 12th 2011 ] - Market Wire

PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes

[ Mon, Dec 12th 2011 ] - Market Wire

Kraig Biocraft Laboratories Receives New Custom Z .. er Configurations for Advanced Fibers Development

[ Mon, Dec 12th 2011 ] - Market Wire

Abbott and Reata Pharmaceuticals Announce Agreeme .. ze Next-Generation Antioxidant Inflammation Modul

[ Mon, Dec 12th 2011 ] - Market Wire

10-Year Study Demonstrates IRIDEX MicroPulsea" La .. ffective for Patients with Diabetic Macular Edema

[ Mon, Dec 12th 2011 ] - Market Wire

Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference

Sun, December 11, 2011

[ Sun, Dec 11th 2011 ] - Market Wire

Pharming granted U.S. patent on C1 inhibitor use in ischemia reperfusion injury indications

[ Sun, Dec 11th 2011 ] - Market Wire

Onyx Pharmaceuticals Announces FDA Standard Revie .. New Drug Application for the Treatment of Relapse

Sat, December 10, 2011

[ Sat, Dec 10th 2011 ] - Market Wire

Onyx Pharmaceuticals Provides Update on Carfilzom .. 3rd American Society of Hematology Annual Meeting

[ Sat, Dec 10th 2011 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. nvestment in Pain Therapeutics, Inc. to Inquire A

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;; u

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ] - Market Wire

Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives

[ Sat, Dec 10th 2011 ] - Market Wire

Exact Sciences Announces Successful Completion of Public Offering of Common Stock

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead maakt tweejaarsgegevens bekend van crucial .. ie van elvitegravir, een integraseremmer voor hiv

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead gibt Zweijahresdaten der Phase-3-Pivotstud .. itegravir, einem Integrasehemmer bei HIV, bekannt

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir, un inibitore dell

[ Sat, Dec 10th 2011 ] - Market Wire

Data Shows Medtronic AdaptiveStima" with RestoreSensora" Provides Pain Relief and Convenience

[ Sat, Dec 10th 2011 ] - Market Wire

Gilead Announces Two-Year Data From Pivotal Phase .. y of Elvitegravir, an Integrase Inhibitor for HIV

Fri, December 9, 2011

[ Fri, Dec 09th 2011 ] - Market Wire

Kahn Swick & Foti, LLC Announces Investigation in .. Report of Possible Federal Manufacturing Suspens

[ Fri, Dec 09th 2011 ] - Market Wire

Amgen to Present at the 22nd Annual Oppenheimer Healthcare Conference

[ Fri, Dec 09th 2011 ] - Market Wire

Shengtai Pharmaceutical, Inc. Announces Annual Meeting Date

[ Fri, Dec 09th 2011 ] - Market Wire

Thoratec Presentation at Oppenheimer Conference to Be Webcast

[ Fri, Dec 09th 2011 ] - Market Wire

HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference

[ Fri, Dec 09th 2011 ] - Market Wire

Quest Diagnostics Care360a" Named Top e-Prescribing Platform by Black Book Rankings

[ Fri, Dec 09th 2011 ] - Market Wire

Lilly for Better Healtha" Expands Website to Incl .. Spanish Health Information and Interactive Tools

[ Fri, Dec 09th 2011 ] - Market Wire

AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations

[ Fri, Dec 09th 2011 ] - Market Wire

VentriPoint Announces Proposed Issuance of Shares for Debt and Credit Facility

[ Fri, Dec 09th 2011 ] - Market Wire

Edwards Lifesciences Forecasts Strong Sales and Earnings Growth in 2012

[ Fri, Dec 09th 2011 ] - Market Wire

CytoSorbents Announces Purchase Agreement for up to $8.5 Million With Lincoln Park Capital

[ Fri, Dec 09th 2011 ] - Market Wire

ULURU Inc. Receives Notice From NYSE Amex Regarding Continued Listing Standards

[ Fri, Dec 09th 2011 ] - Market Wire

BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors

[ Fri, Dec 09th 2011 ] - Market Wire

Smart-Tek Solutions, Inc. Projects Recoup and Possible Loss Exceeded by 4th Quarter's End

[ Fri, Dec 09th 2011 ] - Market Wire

Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology

[ Fri, Dec 09th 2011 ] - Market Wire

Aeterna Zentaris Presents Positive Preclinical Da .. 131, a Highly Selective Erk 1/2 Inhibitor, at San

[ Fri, Dec 09th 2011 ] - Market Wire

Hansen Medical Secures $30 Million Debt Facility

[ Fri, Dec 09th 2011 ] - Market Wire

OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference

Thu, December 8, 2011

[ Thu, Dec 08th 2011 ] - Market Wire

Transcept Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011

[ Thu, Dec 08th 2011 ] - Market Wire

Universal Health Services, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference

[ Thu, Dec 08th 2011 ] - Market Wire

Lpath Files Registration Statement to Raise up to $10 Million

[ Thu, Dec 08th 2011 ] - Market Wire

China's Booming Healthcare Sector Poised to Benefit China Medical Technologies and Sinovac Biotech

[ Thu, Dec 08th 2011 ] - Market Wire

Nektar Reports Affymax Announced FDA Advisory Com .. fit/Risk Profile for Peginesatide for Treatment o

[ Thu, Dec 08th 2011 ] - Market Wire

SEQUEL Trial Results for Qnexa Published in AJCN Show 10% Sustained Weight Loss Over 2 Years

[ Thu, Dec 08th 2011 ] - Market Wire

Bionovo Announces the Publication of its Tissue S .. en Receptor Modulators for Postmenopausal Obesity

[ Thu, Dec 08th 2011 ] - Market Wire

WeedMaps Acquires Android Application WeedLaws

[ Thu, Dec 08th 2011 ] - Market Wire

Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference

[ Thu, Dec 08th 2011 ] - Market Wire

Genomic Health Announces Positive Results of Firs .. Biomarker Discovery Using Next Generation Sequen

[ Thu, Dec 08th 2011 ] - Market Wire

Coronado Biosciences Announces Phase 1 Results of .. e Presented at the American Society of Hematology

[ Thu, Dec 08th 2011 ] - Market Wire

Shire Reports Positive Phase II Results for Inves .. nse (lisdexamfetamine dimesylate) Capsules, (CII)

[ Thu, Dec 08th 2011 ] - Market Wire

Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President

[ Thu, Dec 08th 2011 ] - Market Wire

Isis Pharmaceuticals Holds Webcast to Discuss Recent Additions to its Development Pipeline

[ Thu, Dec 08th 2011 ] - Market Wire

Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder

[ Thu, Dec 08th 2011 ] - Market Wire

Neurologist Survey Confirms Need for Improved Adm .. ation of Parkinson's Disease Acute Rescue Therapy

[ Thu, Dec 08th 2011 ] - Market Wire

Kraig Biocraft Laboratories Announces Filing of I .. on for Spider-Silk and Transgenic Silkworm Techno

[ Thu, Dec 08th 2011 ] - Market Wire

Cord Blood America CEO Matthew Schissler Intervie .. nancial Performance, Stock Price, 2012 Strategies

Wed, December 7, 2011

[ Wed, Dec 07th 2011 ] - Market Wire

Allon Shareholders Approve Balance of October Prospectus Financing

[ Wed, Dec 07th 2011 ] - Market Wire

Lakeland Industries, Inc. Reports Third Quarter Fiscal Year 2012 Financial Results

[ Wed, Dec 07th 2011 ] - Market Wire

International Drug &;; Explosives Detec .. Signs Marketing Agreement With Company From China

[ Wed, Dec 07th 2011 ] - Market Wire

Leading Investigator to Present Clinical Data on .. ternational Diabetes Federation Meetings in Dubai

[ Wed, Dec 07th 2011 ] - Market Wire

VistaGen Therapeutics and Synterys Sign Strategic .. Chemistry Collaboration Agreement for Drug Rescue

[ Wed, Dec 07th 2011 ] - Market Wire

Aoxing Pharmaceutical Company Announces $3.2 Million Financing

[ Wed, Dec 07th 2011 ] - Market Wire

Novelos Therapeutics Closes $6 Million Public Offering

[ Wed, Dec 07th 2011 ] - Market Wire

MuGard Advocate Interviewed on ABC Tampa News at Noon

[ Wed, Dec 07th 2011 ] - Market Wire

Theratechnologies to Discontinue COPD Clinical Program and Accelerate Path to Profitability

[ Wed, Dec 07th 2011 ] - Market Wire

InterMune to Present at Oppenheimer & Co. 22nd Annual Healthcare Conference on Dec. 14

[ Wed, Dec 07th 2011 ] - Market Wire

Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference

[ Wed, Dec 07th 2011 ] - Market Wire

PROLOR Biotech to Present at Oppenheimer 22nd Annual Healthcare Conference

[ Wed, Dec 07th 2011 ] - Market Wire

Stem Cell Therapeutics Announces Reorganization and Management Changes

[ Wed, Dec 07th 2011 ] - Market Wire

Jules Musing to Lead Business Development Effort

[ Wed, Dec 07th 2011 ] - Market Wire

PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes

[ Wed, Dec 07th 2011 ] - Market Wire

Weight Loss and Effects on Diabetes with Qnexa Tr .. Results Presented at the World Diabetes Congress

[ Wed, Dec 07th 2011 ] - Market Wire

Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference

[ Wed, Dec 07th 2011 ] - Market Wire

Inovio Pharmaceuticals Closes $4.0 Million Underwritten Financing

Tue, December 6, 2011

[ Tue, Dec 06th 2011 ] - Market Wire

Merck implante un nouveau sige social en Asie pour les activits de R-D de MSD

[ Tue, Dec 06th 2011 ] - Market Wire

Humana Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference

[ Tue, Dec 06th 2011 ] - Market Wire

Genomic Health Announces Positive Study Results V .. in DCIS Breast Cancer at the 2011 CTRC-AACR San A

[ Tue, Dec 06th 2011 ] - Market Wire

Ergoresearch Announces the Appointment of Its New .. evelopment and Grants Stock Options to Its Vice-P

[ Tue, Dec 06th 2011 ] - Market Wire

China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group

[ Tue, Dec 06th 2011 ] - Market Wire

Quest Diagnostics Launches Simplexaa" Dengue Test .. Molecular Test Approved for Nation's Public and P

[ Tue, Dec 06th 2011 ] - Market Wire

Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim

[ Tue, Dec 06th 2011 ] - Market Wire

The Special Committee of Helix BioPharma Corp. Provides Update to Shareholders

[ Tue, Dec 06th 2011 ] - Market Wire

Aethlon Medical Announces Approval and Initiation .. Research Study to Target Tumor-Secreted Exosomes

[ Tue, Dec 06th 2011 ] - Market Wire

MissionIR Features VistaGen Therapeutics in Exclusive Interview Featuring CEO Shawn Singh

[ Tue, Dec 06th 2011 ] - Market Wire

Avanir Pharmaceuticals Announces Date of Fiscal 2 .. nd Year End Financial Results and Conference Call

[ Tue, Dec 06th 2011 ] - Market Wire

New Study Shows AFECTAIR Significantly Improved D .. e Under Simulated Neonatal Ventilatory Conditions

[ Tue, Dec 06th 2011 ] - Market Wire

Isis Reports Positive Phase 1 Data Demonstrating .. ificant Reductions in apoC-III Protein Levels and

[ Tue, Dec 06th 2011 ] - Market Wire

Varian Medical Systems Adds High Dose Delivery an .. bilities to Clinac and Trilogy Cancer Treatment M

[ Tue, Dec 06th 2011 ] - Market Wire

Data Suggest Optimer's DIFICID Provides Economic .. ment of Clostridium difficile-associated Diarrhea

[ Tue, Dec 06th 2011 ] - Market Wire

Peregrine's Bavituximab Shows 50% Improvement in .. nse Rate in Randomized Phase II Lung Cancer Trial

[ Tue, Dec 06th 2011 ] - Market Wire

Paradigm Business Update as of November 30, 2011

[ Tue, Dec 06th 2011 ] - Market Wire

BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer

Mon, December 5, 2011

[ Mon, Dec 05th 2011 ] - Market Wire

Tolima Gold Inc. (Formerly FMX Ventures Inc.) Closes Reverse Take-Over Transaction

[ Mon, Dec 05th 2011 ] - Market Wire

Titan Medical Inc. Announces Memorandum of Unders .. h India Based Apollo Hospitals Enterprise Limited

[ Mon, Dec 05th 2011 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by Pacific Biosciences

[ Mon, Dec 05th 2011 ] - Market Wire

MiMedx Group Receives HCPCS C-Code from Medicare for EpiFix Reimbursement

[ Mon, Dec 05th 2011 ] - Market Wire

Asantae Announces a New Website, Affiliate Back Office and Compensation Plan

[ Mon, Dec 05th 2011 ] - Market Wire

diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference

[ Mon, Dec 05th 2011 ] - Market Wire

DiaMedica's DM-199 for Type 1 Diabetes Significan .. and Demonstrates a Dramatic Increase in C-Peptide

[ Mon, Dec 05th 2011 ] - Market Wire

Exelixis and Cardium on the Rise as Biotechnology Industry Stays Strong in Volatile Market

[ Mon, Dec 05th 2011 ] - Market Wire

The Medicines Company Invests Equity Stake in GeN .. LLC, Nitric Oxide Delivery and Technology Company

[ Mon, Dec 05th 2011 ] - Market Wire

Peregrine to Report Second Quarter Fiscal Year 20 .. nancial Results After Market on December 12, 2011

[ Mon, Dec 05th 2011 ] - Market Wire

CareFusion Showcases Medication Management Techno .. Society for Health-System Pharmacists Conference

[ Mon, Dec 05th 2011 ] - Market Wire

Sun Healthcare Group, Inc. Pursues Amendment to Its Senior Secured Credit Facility

[ Mon, Dec 05th 2011 ] - Market Wire

Horizon Pharma Announces Launch of DUEXIS(R) (Ibu .. n/Famotidine) 800 mg/26.6 mg in the United States

[ Mon, Dec 05th 2011 ] - Market Wire

Avanafil Data Presented at the European Society of Sexual Medicine Meeting

[ Mon, Dec 05th 2011 ] - Market Wire

Concord Medical Completes its Twelfth Annual Academic Conference

[ Mon, Dec 05th 2011 ] - Market Wire

New Data Demonstrating the Impact of Opioid-Relat .. spital Cost Presented at American Society of Heal

[ Mon, Dec 05th 2011 ] - Market Wire

Radient Pharmaceuticals' Two Abstracts Submitted .. cers Symposium (ASCO) Regarding Onko-Sure Utility

[ Mon, Dec 05th 2011 ] - Market Wire

68% of Healthcare Workers Believe Needlestick Inj .. blem According to a MedPro Safety Products Survey

Sun, December 4, 2011

[ Sun, Dec 04th 2011 ] - Market Wire

Two Year Results of Phase 3 Studies with EYLEAa" .. t AMD Show Sustained Improvement in Visual Acuity

Fri, December 2, 2011

[ Fri, Dec 02nd 2011 ] - Market Wire

Cigna International Expatriate Benefits Expande Rede de Atendimento de Sade no Brasil

[ Fri, Dec 02nd 2011 ] - Market Wire

Rigrodsky & Long, P.A. Announces Its Investigatio .. he Federal Securities Laws by Pacific Biosciences

[ Fri, Dec 02nd 2011 ] - Market Wire

Pfizer Completes Acquisition of Excaliard

[ Fri, Dec 02nd 2011 ] - Market Wire

MDxHealth Enters Agreement with Celldex for Use o .. t in Phase III Rindopepimut Study in Brain Cancer

[ Fri, Dec 02nd 2011 ] - Market Wire

The Law Firm of Levi & Korsinsky Launches an Inve .. ches of Fiduciary Duties and Unjust Enrichment by

[ Fri, Dec 02nd 2011 ] - Market Wire

Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2012 Results

[ Fri, Dec 02nd 2011 ] - Market Wire

Graymark Healthcare Signs Milestone 100th Sleep Center Agreement

[ Fri, Dec 02nd 2011 ] - Market Wire

Skilled Healthcare Group to Present at the Oppenh .. Annual Healthcare Conference on December 13, 2011

[ Fri, Dec 02nd 2011 ] - Market Wire

CareFusion Launches Wireless Diagnostic and Monitoring Neurological Device

[ Fri, Dec 02nd 2011 ] - Market Wire

Amerinet Awards Positron Group Purchasing Agreement

[ Fri, Dec 02nd 2011 ] - Market Wire

Concord Medical Announces Shareholder Resolutions .. ual General Meeting, Board and Management Changes

[ Fri, Dec 02nd 2011 ] - Market Wire

Trimel Pharmaceuticals Corporation Manufacturing Facility Receives GMP Compliance Designation

[ Fri, Dec 02nd 2011 ] - Market Wire

Medivir - TMC435 Will Be Evaluated in a Phase II .. latasvir (BMS 790052) for HCV Genotype-1 Patients

[ Fri, Dec 02nd 2011 ] - Market Wire

Mylan Launches Generic Version of Cyklokapron Injection

[ Fri, Dec 02nd 2011 ] - Market Wire

Oncolytics Biotech Inc. Announces Phase 2 Clinica .. ation with Gemcitabine in Pancreatic Cancer Reach

[ Fri, Dec 02nd 2011 ] - Market Wire

The Ensign Group Acquires Colorado Home Health Company

[ Fri, Dec 02nd 2011 ] - Market Wire

Kraig Biocraft Laboratories to Host Shareholder C .. duct, Scientific and Commercialization Developmen

[ Fri, Dec 02nd 2011 ] - Market Wire

Pharmacyclics Appoints Chief Medical Officer Dr. Lori Anne Kunkel

Thu, December 1, 2011

[ Thu, Dec 01st 2011 ] - Market Wire

MiMedx Group, Inc. to Present at the 6th Annual C .. ar, Aesthetics and Metabolic Disorders Conference

[ Thu, Dec 01st 2011 ] - Market Wire

Novadaq to Present at the Canaccord Genuity 6th Annual Medical Device Conference

[ Thu, Dec 01st 2011 ] - Market Wire

Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011

[ Thu, Dec 01st 2011 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. nvestment in The Copper Companies, Inc. to Inquir

[ Thu, Dec 01st 2011 ] - Market Wire

Direction of Market Influences - Report Highlights Abbott Laboratories and Novartis AG (ADR)

[ Thu, Dec 01st 2011 ] - Market Wire

DiaMedica's DM-204 for Type 2 Diabetes Significan .. od Glucose, Blood Pressure and Cholesterol Levels

[ Thu, Dec 01st 2011 ] - Market Wire

ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188

[ Thu, Dec 01st 2011 ] - Market Wire

Drug Candidates From Alexza and BioSante Pharmaceuticals Inch Closer to Decision Day

[ Thu, Dec 01st 2011 ] - Market Wire

Lead Drug Candidates From Galena Biopharma and Ar .. a Pharmaceuticals Look to Make Big Splash in 2012

[ Thu, Dec 01st 2011 ] - Market Wire

Mylan Confirms First-to-File Patent Challenge Relating to Generessa" Fe

[ Thu, Dec 01st 2011 ] - Market Wire

Mylan Launches Generic Version of Caduet Tablets

[ Thu, Dec 01st 2011 ] - Market Wire

Stellar to Acquire Tribute Pharmaceuticals to Cre .. r North American Specialty Pharmaceutical Company

[ Thu, Dec 01st 2011 ] - Market Wire

MedCath Announces Sale of Ownership Interest in Harlingen Medical Center and HMC Realty, LLC

[ Thu, Dec 01st 2011 ] - Market Wire

Mylan Committed to Expanding Access in Developing .. es to High Quality, Affordable HIV/AIDS Treatment

[ Thu, Dec 01st 2011 ] - Market Wire

Auxilium Pharmaceuticals, Inc. Announces First Pa .. sed in XIAFLEX Study for Frozen Shoulder Syndrome

[ Thu, Dec 01st 2011 ] - Market Wire

Ceregene Completes Enrollment of Second Phase 2 S .. CERE-120 for the Treatment of Parkinson's Disease

[ Thu, Dec 01st 2011 ] - Market Wire

Titan Pharmaceuticals Confirms Regulatory Guidance for Probuphine

[ Thu, Dec 01st 2011 ] - Market Wire

VIVUS to Present at the Deutsche Bank BioFEST Conference

Wed, November 30, 2011

[ Wed, Nov 30th 2011 ] - Market Wire

Universal Health Services, Inc. Announces Agreement to Acquire Knapp Medical Center

[ Wed, Nov 30th 2011 ] - Market Wire

Uroplasty to Present at the Canaccord Genuity 6th .. etics & Metabolic Disorders Medical Device Confer

[ Wed, Nov 30th 2011 ] - Market Wire

Sunrise Senior Living Celebrates 30th Anniversary

[ Wed, Nov 30th 2011 ] - Market Wire

Novadaq and KCI Sign Commercialization Agreements for the SPY System

[ Wed, Nov 30th 2011 ] - Market Wire

BIOLASE Issued Broad New Patent for Treating Eye .. ons, Including Presbyopia, Cataracts and Glaucoma

[ Wed, Nov 30th 2011 ] - Market Wire

Syneron to Participate in the Canaccord Genuity 6 .. thetics &;; Metabolic Disorders Confere

[ Wed, Nov 30th 2011 ] - Market Wire

Boston Scientific Introduces Industry-Leading ICD and CRT-D Device Warranties

[ Wed, Nov 30th 2011 ] - Market Wire

Allon's Intellectual Property Portfolio Strengthened With Additional U.S. Patent

[ Wed, Nov 30th 2011 ] - Market Wire

Cynosure's Cellulaze Cellulite Laser Work Station Receives Korean Regulatory Approval

[ Wed, Nov 30th 2011 ] - Market Wire

Accuray Receives Outstanding Innovative Improvement Award for its CyberKnife System

[ Wed, Nov 30th 2011 ] - Market Wire

Equity Research on Baxter International Inc. and .. - Acquisitions and R&;;D Driving Medic

[ Wed, Nov 30th 2011 ] - Market Wire

Analytical Reports on Celgene Corporation and Bio .. flux of New Products and Uses in Biotech Industry

[ Wed, Nov 30th 2011 ] - Market Wire

Cytori's Celution(R) One Receives European CE Mark Approval

[ Wed, Nov 30th 2011 ] - Market Wire

Cytokinetics Announces Positive Results From Phas .. g CK-2017357 in Patients With Amyotrophic Lateral

[ Wed, Nov 30th 2011 ] - Market Wire

Marina Biotech to Remain Listed on The NASDAQ Global Market

[ Wed, Nov 30th 2011 ] - Market Wire

ProMetic Provides Update on Its Plasma-Derived Pr .. enture With China National Biotech Group ("CNBG")

[ Wed, Nov 30th 2011 ] - Market Wire

Palatin Technologies to Present at Windhover's Therapeutic Area Partnerships Conference

[ Wed, Nov 30th 2011 ] - Market Wire

United States Patent and Trademark Office Upholds .. Patents in Two Re-Examination Cases Brought by Is

Rigel to Present at Oppenheimer Annual Healthcare Conference

_{//health-fitness.news-articles.net/content/2011/ .. at-oppenheimer-annual-healthcare-conference.html}
^{Published in Health and Fitness on Wednesday, December 7th 2011 at 4:46 GMT by Market Wire}

Rigel to Present at Oppenheimer Annual Healthcare Conference -- SOUTH SAN FRANCISCO, Calif., Dec. 7, 2011 /PRNewswire/ --

Rigel to Present at Oppenheimer Annual Healthcare Conference

[ ]

[ Download image ]

SOUTH SAN FRANCISCO, Calif., Dec. 7, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: [ RIGL ]) today announced that Raul Rodriguez, the company's president and chief operating officer, is scheduled to present a company overview at the Oppenheimer 22nd Annual Healthcare Conference in New York City on Wednesday, December 14th at 1:00 p.m. ET.

(Logo: [ http://photos.prnewswire.com/prnh/20030226/RIGLLOGO ])

To access the live audio webcast of the company presentation or the subsequent archived recording, log on to [ www.rigel.com ]. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel ([ www.rigel.com ])
Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its Phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that has completed Phase 1 clinical trials for asthma.

Contact: Ryan Maynard
Phone: 650.624.1284
Email: [ invrel@rigel.com ]

SOURCE Rigel Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.rigel.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire